Zuanic & Associates

Are you curious about the key players, their standings and the driving forces in the cannabis hardware and vaping sector? In this in-depth report, senior analyst Pablo Zuanic from Zuanic & Associates provides some answers. Smoore Holdings: Leading the Way Smoore International...

Canada's cannabis industry is about to hit C$6 billion (nearly $4.4 billion) in retail sales. In its latest report, analysis firm Z&A looks into the thriving year-on-year surge in recreational sales and the worrisome downturn in the medical marijuana sector. The report...

As New York state prepares to issue over 1,500 new licenses across the cannabis supply chain, including 800 dispensary licenses, Z&A's latest report delves into the retail landscape in California, a market with more than 1,000 licensed retail stores. What's driving success in this...

The recent equity raises by Canopy Growth (NASDAQ: CGC) and Columbia Care (OTC: CCHWF) have sparked curiosity about which multi-state operators (MSOs) may follow suit. In its latest report, Zuanic & Associates (Z&A) delves into the financial net debt metrics of 20 MSOs to identify potential...

Zuanic & Associates' latest report outlines a roadmap for the SAFE Banking Act in the US cannabis industry, emphasizing the significance of rescheduling, US exchange uplisting, and a potential "Cole Memo II" (Garland Memo) as more critical catalysts than the SAFE Act itself. Join...

Planet 13 Holdings Inc. (OTC: PLNHF) (OTC: PLTH) is aiming to acquire VidaCann, which operates 26 dispensaries and holds the ninth-largest retail network in Florida. While recreational legalization is the anticipated catalyst for further market growth, Florida's medical marijuana market is...

The Florida cannabis market is experiencing impressive growth, setting the stage for the potential legalization of recreational use. As it stands, Florida's medical marijuana market already boasts an impressive valuation of over $1.4 billion with a remarkable volume growth rate...

Maryland stands as a shining example of a medical cannabis state transitioning smoothly into the recreational market. According to a financial report by Zuanic & Associates, (Z&A), this transition has been particularly beneficial for incumbent medical cannabis players, who have witnessed a...

US legal cannabis sales are predicted to exceed $28 billion in 2023, with promising regulatory developments such as the recommendation to "reschedule" cannabis by the HHS. Canada's cannabis exports have surged to C$160 million, a 50% increase year-on-year, and with new international...

As the cannabis industry continues to evolve, revealing data analysis by Zuanic & Associates sheds light on a captivating paradox: while flower sales have shown signs of growth, their dominance has waned, unveiling a changing landscape. Over nearly three years, flower sales have bloomed by 62...

The Department of Health and Human Services (HHS) suggested the DEA reclassify cannabis as a Schedule III controlled substance under federal law. Assistant Secretary for Health Rachel Levine's letter triggered a much-needed rally in cannabis stocks. In a recent analyst note, a...

The Department of Health and Human Services' recommendation to reclassify marijuana as a Schedule III drug under the Controlled Substances Act set off ripples across the cannabis market. One day following Wednesday's news, MSOS ETF (ARCA: MSOS) surged by 21%. Notable companies also...

Recent news that the Department of Health and Human Services (HHS) is recommending the reclassification of marijuana as a Schedule III drug under the Controlled Substances Act has ignited significant market reactions. On the day following the report, MSOS ETF (ARCA: MSOS) surged...

Zuanic & Associates' recent report unveils the movers and shakers in the flower segment, shedding light on their market shares, pricing strategies and fortunes. The second quarter of 2023 saw some intriguing shifts in the sector. When it comes to market leaders in the flower segment,...

In a recent report by Zuanic & Associates, a comprehensive analysis of Canada's cannabis industry highlights both promising growth trends and concerning gaps in comparison to the United States. The data reveals that while Canada's cannabis market is experiencing decent growth, it falls...